Skip to content
TrackPodcasts
newsFeb 22, 202311:00pending

Why Indian Pharma struggles with quality control

Daybreak

About this episode

From February 26, the Union Health Ministry will organise a two-day 'Chintan Shivir'  to explore ways to build trust on Indian drugs, cosmetics and medical devices.

Despite being called 'the pharmacy of the world,' time and again, the Indian pharmaceutical industry has received criticism for substandard quality. The most recent such incident was when the deaths of children in Gambia and Uzbekistan were allegedly linked to cough syrups manufactured in India.

Why does Indian Pharma still struggle with quality control?

Tune in to find out.

Get every episode summarized

Each time Daybreak publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Why Indian Pharma struggles with quality control

Daybreak

0:00
11:00

More episodes

More from Daybreak

View all episodes →